ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

ClinicalTrials.gov ID: NCT05826535

Public ClinicalTrials.gov record NCT05826535. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of Rondecabtagene Autoleucel, a CD19/CD20 Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy in Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Study identification

NCT ID
NCT05826535
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Lyell Immunopharma, Inc.
Industry
Enrollment
270 participants

Conditions and interventions

Interventions

  • Cyclophosphamide Drug
  • Fludarabine Drug
  • Rondecabtagene autoleucel (ronde-cel) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2023
Primary completion
Dec 30, 2028
Completion
Jun 29, 2031
Last update posted
May 6, 2026

2023 – 2031

United States locations

U.S. sites
31
U.S. states
20
U.S. cities
29
Facility City State ZIP Site status
University of California-Irvine Medical Center Irvine California 92697 Recruiting
Cedars-Sinai Medical Center Los Angeles California 90048 Recruiting
University of California, Los Angeles (UCLA) Medical Center Los Angeles California 90095 Recruiting
Scripps Clinic San Diego California 92037 Recruiting
Colorado Blood Cancer Institute Denver Colorado 80218 Recruiting
Augusta University Medical Center Augusta Georgia 30912 Recruiting
Indiana Blood and Marrow Transplantation Indianapolis Indiana 46237 Recruiting
University of Iowa Iowa City Iowa 52242 Recruiting
University of Louisville Brown Cancer Center Louisville Kentucky 40202 Recruiting
Louisiana State University Health Sciences Center Shreveport Louisiana 71130 Recruiting
Corewell Health Grand Rapids Michigan 49503 Recruiting
University of Nebraska Medical Center Omaha Nebraska 68198 Recruiting
John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey 07601 Recruiting
University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico 87131 Recruiting
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 Recruiting
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York New York 10021 Recruiting
Montefiore Medical Center The Bronx New York 10461 Recruiting
Atrium Health Wake Forest Baptist Winston-Salem North Carolina 27157 Recruiting
University of Cincinnati (UC) Physicians Company, LLC Cincinnati Ohio 45267 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
Lehigh Valley Topper Cancer Center Institute Allentown Pennsylvania 18103 Recruiting
Thomas Jefferson University Philadelphia Pennsylvania 19107 Recruiting
West Penn Hospital Pittsburgh Pennsylvania 15224 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37212 Recruiting
Baylor University Medical Center Dallas Texas 75246 Recruiting
Texas Transplant Institute San Antonio Texas 78229 Recruiting
Huntsman Cancer Institute Salt Lake City Utah 84112 Recruiting
Intermountain Healthcare Salt Lake City Utah 84143 Recruiting
Virginia Oncology Associates Norfolk Virginia 24502 Recruiting
Virginia Commonwealth University-Massey Cancer Center Richmond Virginia 23298 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05826535, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05826535 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →